Collagen peptide, dipeptide and malady inhibitor
    1.
    发明申请
    Collagen peptide, dipeptide and malady inhibitor 有权
    胶原肽,二肽和恶性抑制剂

    公开(公告)号:US20120258919A1

    公开(公告)日:2012-10-11

    申请号:US13523438

    申请日:2012-06-14

    摘要: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.

    摘要翻译: 本发明要解决的问题是提供:对于抑制诸如骨质疏松症,骨关节炎和压力性溃疡等各种疾病的肽分子的主体,特别是容易吸收到体内的二肽 肠 包含二肽作为必需二肽的胶原肽; 以及包含二肽作为基本有效成分的疾病抑制剂。 作为解决上述问题的方法,本发明的胶原肽的特征在于,含有具有Hyp-Gly结构的二肽作为必需二肽的二肽。 根据本发明的二肽的特征在于具有Hyp-Gly的结构。 根据本发明的疾病抑制剂的特征在于包含具有Hyp-Gly结构作为必需有效成分的二肽。

    Collagen peptide, dipeptide and malady inhibitor
    4.
    发明授权
    Collagen peptide, dipeptide and malady inhibitor 有权
    胶原肽,二肽和恶性抑制剂

    公开(公告)号:US08410062B2

    公开(公告)日:2013-04-02

    申请号:US13523438

    申请日:2012-06-14

    IPC分类号: A61K38/05

    摘要: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.

    摘要翻译: 本发明要解决的问题是提供:对于抑制诸如骨质疏松症,骨关节炎和压力性溃疡等各种疾病的肽分子的主体,特别是容易吸收到体内的二肽 肠 包含二肽作为必需二肽的胶原肽; 以及包含二肽作为基本有效成分的疾病抑制剂。 作为解决上述问题的方法,本发明的胶原肽的特征在于,含有具有Hyp-Gly结构的二肽作为必需二肽的二肽。 根据本发明的二肽的特征在于具有Hyp-Gly的结构。 根据本发明的疾病抑制剂的特征在于包含具有Hyp-Gly结构作为必需有效成分的二肽。

    Collagen peptide, dipeptide and malady inhibitor
    7.
    发明申请
    Collagen peptide, dipeptide and malady inhibitor 有权
    胶原肽,二肽和恶性抑制剂

    公开(公告)号:US20110166365A1

    公开(公告)日:2011-07-07

    申请号:US12443298

    申请日:2008-11-14

    IPC分类号: C07D207/12

    摘要: A problem that the present invention is to solve is to provide: a main body of a peptide molecule which is effective for inhibition of various maladies such as osteoporosis, osteoarthritis and pressure ulcer, particularly, a dipeptide which is easy to absorb into a body in an intestine; a collagen peptide which comprises the dipeptide as an essential dipeptide; and a malady inhibitor which comprises the dipeptide as an essential effective component. As a means of solving such a problem, a collagen peptide according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential dipeptide. A dipeptide according to the present invention is characterized by having a structure of Hyp-Gly. A malady inhibitor according to the present invention is characterized by comprising a dipeptide having a structure of Hyp-Gly as an essential effective component.

    摘要翻译: 本发明要解决的问题是提供:对于抑制诸如骨质疏松症,骨关节炎和压力性溃疡等各种疾病的肽分子的主体,特别是容易吸收到体内的二肽 肠 包含二肽作为必需二肽的胶原肽; 以及包含二肽作为基本有效成分的疾病抑制剂。 作为解决上述问题的方法,本发明的胶原肽的特征在于,含有具有Hyp-Gly结构的二肽作为必需二肽的二肽。 根据本发明的二肽的特征在于具有Hyp-Gly的结构。 根据本发明的疾病抑制剂的特征在于包含具有Hyp-Gly结构作为必需有效成分的二肽。

    COLLAGEN PEPTIDE COMPOSITION AND FOOD OR BEVERAGE CONTAINING THE SAME
    9.
    发明申请
    COLLAGEN PEPTIDE COMPOSITION AND FOOD OR BEVERAGE CONTAINING THE SAME 审中-公开
    胶原蛋白组合物和含有其的食物或饮料

    公开(公告)号:US20100068342A1

    公开(公告)日:2010-03-18

    申请号:US12312513

    申请日:2007-11-15

    IPC分类号: A23L1/305 A23L1/0562

    摘要: An object of the present invention is to elucidate a collagen peptide composed of oligopeptides having ability to enter the blood higher than that of conventional collagen peptides and thus to provide a food or beverage mixed with the collagen peptide. The present invention provides a collagen peptide composition obtainable by digesting a collagen or gelatin with protease, which comprises 70% to 100% by weight of peptides with a molecular weight 500 or more to 3000 or less, less than 10% by weight of peptides with a molecular weight of less than 500, and less than 20% by weight of peptides with a molecular weight of more than 3000, based on the total weight of the composition, wherein the ratio of N-terminal glycine residues to total of the N-terminal amino acid residues of the peptides in the composition is 33 mol % or more to 65 mol % or less.

    摘要翻译: 本发明的目的是阐明由具有比常规胶原肽更高的进入血液的能力的寡肽构成的胶原肽,从而提供与胶原肽混合的食品或饮料。 本发明提供了一种通过用蛋白酶消化胶原蛋白或明胶获得的胶原肽组合物,其包含70%至100%重量的分子量为500或更多至3000或更小,少于10重量% 基于组合物的总重量,分子量小于500且小于20重量%的分子量大于3000的肽,其中N-末端甘氨酸残基与N- 组合物中肽的末端氨基酸残基为33摩尔%以上至65摩尔%以下。